Exchange: NASDAQ·Updated 07:00 AM EDT
RMTI logo

RMTI Rockwell Medical Inc

$7.80
$0.185
(2.32%)
Pre-Market
Prev Close $7.99
Reported EarningsAug 13
Mkt Cap$32.18M
Vol423.00

About RMTI

Rockwell Medical, Inc. is a biopharmaceutical company, which engages in the development of treatment for anemia, kidney disease, iron deficiency, and hemodialysis. Its products include Triferic, CitraPure, RenalPure and SteriLyte. The company was founded by Robert L. Chioini on October 25, 1996 and is headquartered in Wixom, MI.
49

Neutral Sentiment

How do you feel about RMTI?

Advertisement|Remove ads.